Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Johnson and Johnson
Merck
Moodys
McKinsey

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Litigation Details for Aventis Pharma Deutschland GMBH v. Lupin Ltd. (E.D. Va. )

See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Aventis Pharma Deutschland GMBH v. Lupin Ltd.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Aventis Pharma Deutschland GMBH v. Lupin Ltd. (E.D. Va. )

Date Filed Document No. Description Snippet Link To Document
2006-07-17 234 Schering’s ‘258 Patent On May 6, 1986, Schering’s Patent No. 4,587,258 (the ‘258 patent or “Gold patent… U.S. Patent Application No. 635,390, which eventually issues into U.S. Patent No. 4,587,258 (the ‘… of contention involves United States Patent No. 4,587,258, which Aventis licensed from Schering and…for being “anticipated by Gold U.S. 4,587,258” (the ‘258 patent). Id. at LUPRAM 000269-270. The Examiner… enough, the ‘722 patent is a subsequent patent to a patent known as the ‘258 patent, which was approved External link to document
2005-12-02 37 Aventis owns U.S. Patent No. 5,061,722, known as the “ ‘722 patent.” The ‘722 patent involves a pharmaceutical… drug claimed in a patent or the use of which is claimed in a patent, . . . if the…product claimed in a patent or the use of which is claimed in a patent before the expiration… the “pioneer” patent. Id. In this case, Lupin Ltd. certified that Plaintiffs’ patent “is invalid or …SCHWARTZ, HERBERT , PATENT LAW AND PRACTICE , §3.V.A. (4th. Ed. 2003)[hereinafter “Patent Law and Practice External link to document
2006-01-18 46 Aventis owns U.S. Patent No. 5,061,722, known as the “‘722 patent.” The ‘722 patent involves a pharmaceutical…status of the “pioneer” patent, Lupin Ltd. certified that Plaintiffs’ patent “is invalid or will not …‘722 patent, constitutes infringement of one or more of the claims of that patent under…‘722 patent under 35 U.S.C. § 271(b) by actively inducing Lupin Ltd. to infringe the ‘722 patent.” Id…developing a generic version of a patented drug before the patent has expired, and 2) provide the innovative External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Medtronic
Baxter
McKinsey
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.